The Claim
The GPR35 receptor does not exhibit constitutive interaction with β-arrestin-2, and its engagement with arrestin proteins is strictly dependent on agonist binding, indicating a signaling bias away from arrestin pathways under basal conditions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The GPR35 receptor only interacts with β-arrestin-2 when a specific activating molecule is present; without that molecule, no interaction occurs, and the receptor does not signal through arrestin pathways under normal conditions.
See the scientific wording
The GPR35 receptor does not exhibit constitutive interaction with β-arrestin-2, and its engagement with arrestin proteins is strictly dependent on agonist binding, indicating a signaling bias away from arrestin pathways under basal conditions.
The GPR35 receptor is naturally active without any trigger and constantly signals through specific G proteins that strengthen the gut barrier, but it never interacts with β-arrestin-2 unless a matching molecule binds to it. When that molecule binds, the receptor changes shape enough to pull in β-arrestin-2, but without it, β-arrestin-2 stays completely disconnected.
What the research says
1 studyThis study found that GPR35 doesn't activate arrestin proteins unless a drug or molecule turns it on — it stays quiet on arrestin pathways when left alone. So, unlike some other receptors, it doesn't accidentally trigger this pathway by itself.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.